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During oncogenic transformation, microRNA levels of the translation-regulatory factor let-7 correlate
inversely with expression of the HMGA2 oncoprotein. In a recent issue of Cell, Yu et al. (2007) now provide
evidence that the let-7/HMGA2 linkage could be a signature of cancer stem cells in vivo, with broader
implications for stem cell research.The physiological significance of the
strong link between the let-7 family of
tumor-suppressor mircoRNAs (miRNAs)
and the high-mobility group AT-hook
2 (HMGA2) oncoprotein during oncogenic
transformation has remained unclear,
because researchers have almost exclu-
sively investigated established human
cancer cell lines. Song, Lieberman, and
colleagues (Yu et al., 2007) now provide
compelling evidence that the let-7/
HMGA2 connection is indeed of clinical
importance. Interestingly, it emerged that
this linkage might represent a functional
signature of elusive cancer stem cells
(CSCs), referred to as tumor-inducing
cells by Yu et al. (2007), for at least some
types of cancer. These findings reach be-
yond tumorigenesis and likely impinge on
embryonic stem cell (ESC) biology.
According to the cancer stem cell
hypothesis, CSCs are rare, slow-dividing,
and self-renewing cells. Isolated breast
CSCs exhibit a CD44+CD24/low pheno-
type and can grow into so-called mam-
mospheres in suspension culture, which
is a measure of self-renewal capability.
Based on these criteria, Yu et al. (2007)
took advantage of evidence that chemo-
therapy-resistant CSCs might reside in
tumors of breast cancer patients (Al-Hajj,
2007) and enriched these cells before
and after chemotherapy. Chemotherapy
increased the fraction of CSCs in tumor
specimens by about 14-fold, which is, of
course, an unsettling finding considering
current cancer treatment regimens. This
selection strategy was subsequently ap-
plied to enrich CSCs in the established hy-
pertriploid humanbreast adenocarcinoma
cell line SKBR3. After injecting SKBR3
cells into chemotherapy-treated, immuno-
compromised mice, and subsequent to8 Cell Stem Cell 2, January 2008 ª2008 Elsetwo serial in vivo passages of xenografts,
a progenitor cell line termed SK-3rd was
generated that contained 16% CSCs.
Yu et al. (2007) established that the
mammosphere-derived SK-3rd cells ex-
hibited self-renewing and in vitro differ-
entiating capability, with a significant
increase in tumor formation and metasta-
sis. Also, western blot analysis demon-
strated that cells expressed ESC marker
OCT4, which was downregulated during
induced in vitro differentiation. Taken to-
gether, this shows that CSCs display fea-
tures attributed to multipotent stem cells.
It would have been interesting, however,
had the authors also obtained information
on the expression of other prominent ESC
markers, suchasSOX2,NANOG,orUTF1,
whichcouldprovide insight into thedegree
of stemness of CSCs.
Yu et al. (2007) demonstrated that
among 52 miRNAs analyzed in mammo-
sphere-derived SK-3rd cells, the most
significantly reduced expression was for
the let-7 family. In addition to HMGA2,
RAS is also a prominent let-7 target, and
the expression of both oncoproteins,
which is high in SK-3rd and greatly re-
duced in differentiated tumor cells, was
inversely correlated with that of let-7. Im-
portantly, the authors then turned their
attention back to CSCs enriched directly
from clinical specimens and showed that
let-7 expression was also markedly re-
duced when compared with normal
breast or nonselected tumor cells. Obvi-
ously, this is a very important result that
strengthened the clinical significance of
their findings obtained with sphere-de-
rived SK-3rd cells. Notably, others have
also recently reported an inverse in vivo
correlation between let-7 and HMGA2 in
primary tumors derived from 100 patientsvier Inc.diagnosedwith ovarian cancer (Shell et al.,
2007; Park et al., 2007).
Yu et al. (2007) then confirmed the func-
tional role of the let-7 signature of CSCs
by demonstrating that self-renewal and
maintenance of an undifferentiated state
required reduced let-7 levels. Intriguingly,
inhibition of let-7 activity in SKBR3
cells through antisense oligonucleotides
(ASOs) enhanced their self-renewal ca-
pability, thereby indicating some degree
of induced dedifferentiation. Furthermore,
let-7 targeting of RAS appeared to control
self-renewal of CSCs, whereas HMGA2
mediated maintenance of an undifferenti-
ated state. The latter nuclear factor is also
involved in cell proliferation control be-
cause a knockdown of HMGA2 in differ-
entiating SK-3rd cells reduced prolifer-
ation rates.
A very interesting picture now emerges
in which the let-7/HMGA2 linkage in
CSCs described by Yu et al. (2007) is strik-
ingly similar to that in ESCs (Figure 1). let-7
levels in ESCs are also greatly reduced, in-
crease with the level of differentiation, and
are inversely correlated with the expres-
sion of HMGA2 (Lee et al., 2005; Li et al.,
2006). The finding that reduced let-7 levels
control self-renewal and differentiation in
CSCs through RAS and HMGA2, respec-
tively, may hint at similar functional roles
in ESCs. In fact, in human and mouse
ESCs,HMGA2 isknown toplaya role indif-
ferentiation control and cell proliferation
(Li etal., 2007). It is almostcertain thatother
let-7 targets are involved, but the pygmy
phenotype of HMGA2 knockout mice with
significantly reduced fat tissue (Zhou
et al., 1995) confirms a central role for the
let-7/HMGA2 connection in this scenario.
Another indication that this connection
is of functional significance in ESCs
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PreviewsFigure 1. The Inverse Correlation between let-7 and HMGA2 Expression in Cancer Stem
Cells and Embryonic Stem Cells
See text for details. let-7 ASOs refer to antisense oligonucleotides that target the let-7 family of miRNAs
and induce dedifferentiation of tumor cells. This is possible because of the high degree of sequence
conservation within this family. Whether a similar effect can be achieved with differentiated somatic cells
is not known.comes from a recent study by Weedon
et al. (2007), who described an associa-
tion between increased human height
and a particular single nucleotide poly-
morphism (SNP) in the HMGA2 gene—
rs1042725. Upon closer inspection, we
find that rs1042725 maps proximal to
the third functional binding site for let-7
in the 30 untranslated region (30UTR) of
HMGA2 mRNA (see Shell et al., 2007 for
an analysis of let-7 binding sites in the
30UTR). This SNP is located ten nucleo-
tides downstream of the let-7 seed
sequence. It is therefore tempting to sug-
gest that HMGA2 expression in the indi-
viduals identified with increased height
may be augmented during early embry-
onic development as a result of de-
creased association of let-7 with this
30UTR translation-regulatory element.Based on HMGA2’s known role in differ-
entiation control and stem cell prolifera-
tion, elevated levels could then affect the
population size of stem or early progenitor
cells.
The growing evidence for an important
functional role of reduced let-7 levels
both in ESCs and CSCs raises an interest-
ing question. Is there a causative relation-
ship between the control of let-7 expres-
sion and stemness? Yu et al. (2007)
provide the first glimpse of an answer by
showing that ASOs targeting let-7 trig-
gered dedifferentiation of SKBR3 cells
(see Figure 1). Based on this finding, one
might now be tempted to explore let-7
ASOs as a component of strategies for
transcription factor-induced pluripotency
in human somatic cells (Takahashi et al.,
2007). This is, of course, but one ofCell Stemmany pressing questions regarding the
let-7/HMGA2 relationship to stemness.
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Note Added in Proof
A related paper showing that let-7 expression is
also reduced in the primitive fraction of a mouse
mammary epithelial cell line was published after
this article was completed (Ibarra, I., Erlich, Y., Mu-
thuswamy, S.K., Sachidanandam, R., and Hannon,
G.J. [2008]. A role for microRNAs in maintenance
of mouse mammary epithelial progenitor cells.
Genes Dev. 21, 3238–3243).Cell 2, January 2008 ª2008 Elsevier Inc. 9
